Quantification of relevant metabolites in apoptotic bodies from HK-2 cells by targeted metabolomics based on liquid

Samuel Bernardo-Bermejo1, Ana B Fernández-Martínez2, Francisco Javier Lucio-Cazaña3

  • 1Universidad de Alcalá, Departamento de Química Analítica, Química Física e Ingeniería Química, Ctra. Madrid-Barcelona Km. 33.600, 28871, Alcalá de Henares (Madrid), Spain.

Analytica Chimica Acta
|October 13, 2024
PubMed
Abstract

Insights

This study developed a new LC-MS method to quantify metabolites in apoptotic bodies, revealing key biomarkers that differentiate cell death and proliferation signals. This advances understanding of cellular communication and disease mechanisms.

Area of Science:

  • Cell Biology
  • Analytical Chemistry
  • Metabolomics

Background:

  • Apoptotic bodies are crucial for intercellular communication, carrying diverse biomolecules.
  • First-generation apoptotic bodies can induce apoptosis, while second-generation bodies promote proliferation, highlighting distinct biological roles.
  • Quantifying metabolite changes in apoptotic bodies is essential for understanding these opposing cellular effects.

Purpose of the Study:

  • To develop and validate a targeted metabolomics method for quantifying specific metabolites in apoptotic bodies.
  • To identify potential biomarkers indicative of metabolic differences in apoptotic bodies.
  • To elucidate the biological roles of quantified metabolites in cellular processes.

Main Methods:

  • Development of a liquid chromatography coupled with quadrupole-Orbitrap mass spectrometry (LC-(Q-Orbitrap)MS) method.
  • Optimization involved testing different columns (HILIC selected), gradients, and collision energies.
  • Quantitative analysis utilized parallel reaction monitoring (PRM) and method validation included linearity, LOD/LOQ, matrix effects, accuracy, and precision.

Main Results:

  • A robust LC-(Q-Orbitrap)MS method was established for the targeted quantification of metabolites in apoptotic bodies.
  • Method validation demonstrated high sensitivity with limits of detection ranging from 0.02 to 1.4 ng/mL.
  • Nine key metabolites were quantified, providing insights into metabolic differences and biological relevance.

Conclusions:

  • The first targeted metabolomics methodology for quantifying metabolites in HK-2 cell-derived apoptotic bodies was successfully developed.
  • Specific metabolite concentrations (e.g., pyridoxine, kynurenine, creatine, phenylacetylglycine) were determined in response to cisplatin and UV treatments.
  • The quantified metabolite levels provide valuable data for understanding their specific biological roles in apoptosis and proliferation.

Related Concept Videos